CELK AB Share Price Nasdaq Stockholm
Equities
SE0009189657
Advanced Medical Equipment & Technology
Sales 2024 * | 2.43B 231M 0 18.26B | Sales 2025 * | 2.78B 264M 0 20.88B | Capitalization | 3.14B 298M 0 23.59B |
---|---|---|---|---|---|
Net income 2024 * | -74M -7.04M - -556M | Net income 2025 * | -16M -1.52M - -120M | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | 630M 59.94M 0 4.74B | Net cash position 2025 * | 311M 29.56M 0 2.34B | EV / Sales 2025 * | 1.02 x |
P/E ratio 2024 * |
-41.9
x | P/E ratio 2025 * |
-193
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.54% |
Latest transcript on CELK AB
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 11-19 | |
Director of Finance/CFO | 39 | 30/11/21 | |
Marius Balger
COO | Chief Operating Officer | 56 | 28/02/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
CHM | Chairman | 79 | 25/04/22 |
John Mackay
BRD | Director/Board Member | 62 | 31/12/22 |
Director/Board Member | 68 | 17/12/19 |
1st Jan change | Capi. | |
---|---|---|
+6.37% | 213B | |
+10.21% | 184B | |
+28.22% | 153B | |
+34.42% | 113B | |
+0.80% | 63.66B | |
+19.21% | 53.53B | |
+0.13% | 49.11B | |
-4.16% | 38.73B | |
+2.39% | 36.26B |